Type 2 Immunity: Initiation, Maintenance, Homeostasis and Pathology
joint with Pathogenic Processes in Asthma and COPD
Organizer(s): Richard M. Locksley and Judith E. AllenDate: January 10 - 15, 2013
Location: Santa Fe Community Convention Center, Santa Fe, NM, USA
Diseases associated with allergy and asthma are increasing in developed countries, with great consequences to healthcare costs. Often, these diseases reflect pathologic outcomes of type 2 immunity, and are characterized by infiltration of tissues with Th2 cells and eosinophils, by elevations in serum IgE and by alterations in epithelial and mucosal biology. These responses did not evolve to cause allergies, and clues to the evolutionary pressure to maintain this type of immune response may exist in the response to intestinal helminths, which cause chronic infestations in all vertebrate species on earth. This meeting will bring together scientists from diverse disciplines to discuss new findings in type 2 immunity that suggest close associations of these responses with tissue homeostasis, mucosal microbiomes and immune integrity that optimize overall fitness of the organism. The goals of this meeting are as follows: 1) to identify gaps in our understanding of type 2 immunity and facilitate future research advances in the field; 2) to promote the development of novel therapeutic strategies against diseases associated with type 2 immunity; and 3) to encourage cross-disciplinary collaborations and establish an ongoing dialogue for future research. Opportunities for interdisciplinary interactions will be significantly enhanced by the concurrent meeting on Pathogenic Processes in Asthma and COPD, which will share a keynote address and two plenary sessions with this meeting.
Scholarship Deadline: September 10 2012
Discounted Abstract Deadline: September 10 2012
Abstract Deadline: October 10 2012
Discounted Registration Deadline: November 8 2012
We gratefully acknowledge additional support for this conference from:
We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:
We gratefully acknowledge the generous grant for this conference provided by:National Institute of Allergy and Infectious Diseases (NIAID)
Grant No. 1R13AI102504-01
The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.